3.6. summary evidence recommendations management renal tumours. summary evidencelea variety renal tumours exist approximately 15% benign .3the common renal tumours three malignant types rcc (clear cell, papillary chromophobe) two benign renal tumours: oncocytoma angiomyolipoma.3a definitive histopathological diagnosis oncocytoma cannot made needle-core biopsy, chrcc show intratumoural heterogeneity areas similar oncocytoma.3histological work results bosniak iii cysts shows low risk malignant potential/course.2 recommendationsstrength ratingmanage bosniak type iii cysts localised rcc, offer active surveillance (as).weakmanage bosniak type iv cysts localised rcc.strongoffer patients biopsy-proven oncocytoma oncocytic renal tumours acceptable alternative surgery ablation.weaktreat angiomyolipoma (aml) selective arterial embolisation nephron-sparing surgery, in:large tumours (a recommended threshold intervention exist);females childbearing age;patients follow-up access emergency care may inadequate;persistent pain acute repeated bleeding episodes.weakoffer systemic therapy (everolimus) patients need therapy surgically unresectable amls amendable embolisation.weak